Send mail to Author

Long-term effects of ruxolitinib versus best available therapy on bone marrow fibrosis in patients with myelofibrosis (Article)

Please indicate your contact information and select, which author you want to contact.



 
 _    _      ___      _____      ___     __   _    __   __  
| || | ||   / _ \\   /  ___||   / _ \\  | || | ||  \ \\/ // 
| || | ||  / //\ \\ | // __    / //\ \\ | '--' ||   \ ` //  
| \\_/ || |  ___  ||| \\_\ || |  ___  ||| .--. ||    | ||   
 \____//  |_||  |_|| \____//  |_||  |_|||_|| |_||    |_||   
  `---`   `-`   `-`   `---`   `-`   `-` `-`  `-`     `-`'
 


Back to frontdoor view

OPUS4 Logo